Get the Stockscreener App
2.11
4.52%
-0.10
After Hours:
2.11
iBio Inc stock is traded at $2.11, with a volume of 1.26M.
It is down -4.52% in the last 24 hours and down -21.85% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$2.21
Open:
$2.2
24h Volume:
1.26M
Relative Volume:
0.23
Market Cap:
$72.89M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.3182
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
-1.86%
1M Performance:
-21.85%
6M Performance:
+268.17%
1Y Performance:
-42.66%
1-Day Range:
$2.025
$2.20
1-Week Range:
$2.025
$2.495
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.11 | 76.34M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Oppenheimer | Outperform |
| Oct-17-25 | Initiated | Leerink Partners | Outperform |
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
View All
iBio Inc Stock (IBIO) Latest News
IBIO: Chardan Capital Maintains 'Buy' Rating with Steady Price T - GuruFocus
IBIO: Chardan Capital Maintains 'Buy' Rating with Steady Price Target | IBIO Stock News - GuruFocus
IBIO Inc (NASDAQ:IBIO) Secures $26 Million Lifeline Amid Quarterly Earnings Miss - ChartMill
iBio (IBIO) Bolsters Pipeline with $26M Financing - GuruFocus
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewswire
IBIO stock soars 12% pre-market after company announces $26 million private placement - MSN
Fed Watch: Will iBio Inc benefit from green energy policiesMarket Growth Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Finviz
Forecast Cut: What is the implied volatility of Teck Resources LimitedTrade Signal Summary & Technical Confirmation Trade Alerts - baoquankhu1.vn
IBIO Stockholders Sell Shares Without Company Receiving Proceeds - GuruFocus
iBio (NASDAQ:IBIO) Stock Price Down 3.6%Here's Why - MarketBeat
What is the PEG ratio of iBio Inc.2025 EndofYear Setup & Growth Focused Investment Plans - mfd.ru
ImmunityBio Stock Rises 25.3% to $6.92 - intellectia.ai
Aug Analyst Calls: What is the PEG ratio of iBio Inc2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
LifeSci Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途资讯
Will iBio Inc outperform its industry peersJuly 2025 Update & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
iBio (NYSE:IBIO) Stock Price Down 5.9%Here's What Happened - MarketBeat
Macro Review: Is iBio Inc stock positioned for long term growthDip Buying & Accurate Entry/Exit Alerts - Bộ Nội Vụ
Forecast Cut: How institutional buying supports iBio Inc. stockJuly 2025 Technicals & Daily Stock Trend Reports - Bộ Nội Vụ
iBio Announces Private Placement to Fund Pipeline Expansion - The Globe and Mail
iBio Signs Multiple Material Agreements - TradingView — Track All Markets
IBIO announces private placement financing to raise ~$26M - MSN
Key Highlights: Strategic Ratings and Milestones - timothysykes.com
iBio (NYSEMKT:IBIO) Trading 8.3% HigherHere's Why - MarketBeat
IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement - Stocktwits
LifeSci Capital Rates iBio with $5 Target Amid Antibody Advances - StocksToTrade
iBio stock jumps after $26mn private placement announcement | Tap to know more | Inshorts - Inshorts
IBio, Inc. announced that it expects to receive $26 million in funding - marketscreener.com
LifeSci Capital Boosts iBio’s Prospects with Positive Rating - timothysykes.com
IBio shares rally after $26 million private placement funding secured - MSN
iBio secures $26 million in private placement financing By Investing.com - Investing.com Nigeria
Ibio stock soars after securing $26M in private placement financing - Investing.com Nigeria
Ibio stock soars after securing $26M in private placement financing By Investing.com - Investing.com South Africa
iBio (IBIO) Secures $26M in Private Placement Financing - GuruFocus
iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
iBio (IBIO) Secures $26M Financing to Advance Cardiometabolic Pr - GuruFocus
iBio secures $26 million in private placement financing - Investing.com
iBio Announces $26 Million Private Placement - manilatimes.net
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
How iBio Inc. stock performs in interest rate cyclesQuarterly Trade Summary & Expert Curated Trade Setups - ulpravda.ru
Is iBio Inc. stock supported by strong fundamentalsTrade Performance Summary & Reliable Entry Point Trade Alerts - ulpravda.ru
Will iBio Inc. stock attract ESG investorsJuly 2025 Drop Watch & AI Based Trade Execution Alerts - Улправда
Will iBio Inc. stock continue upward momentumQuarterly Risk Review & Reliable Intraday Trade Plans - Улправда
How institutional buying supports iBio Inc. stockMarket Correction Analysis & Small Capital Gains - Улправда
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):